Editor's Choice

Stay up to date with the latest updates from the global pharmaceuticals industry.

Latest Update

Diabetes drug alleviates anxiety in mice
05 June, 2019
The antidiabetic medication metformin reduces anxiety-like behaviours in...
> read more

Editor's Choice

Choosing the right drug to fight cancer
Tuesday, June 04, 2019 by Canadian researchers have just discovered a molecular mechanism that drives cancer progression, providing the possibility for the use of precision medicine whereby patients are matched...

Artificial intelligence provides boost to proteome research
Thursday, May 30, 2019 by Using artificial intelligence (AI), researchers at the Technical University of Munich (TUM) have developed software to analyse the proteins from any organism significantly faster and...

Pregnancy protein mechanism identified as potential drug target
Thursday, May 30, 2019 by Researchers at Flinders University, Australia, have discovered the mechanism involved in dealing with biological stresses and associated protein misfolding in pregnant women

Clinical Innovation Partnership set for September, plus get 15% off here
Wednesday, May 29, 2019 by On 11 and 12 of September, Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials

Potential new therapy for oesophageal cancer
Tuesday, May 21, 2019 by Researchers at the Medical University of South Carolina (MUSC) have found a way to target drug-resistant oesophageal cancer cells by exploiting the different energy needs of...

Twitter launches new initiative to combat vaccine myths on its platform
Tuesday, May 21, 2019 by Twitter announced this week that it plans to present reliable information about vaccines to help combat misconceptions being spread on the platform

Orphan drugs market to reach $224 billion by 2024
Tuesday, April 30, 2019 by Breakthrough treatments will contribute to a 12% compound annual growth rate for orphan drugs through to 2024, according to a report by Evaluate Pharma.

Deadly measles outbreaks on the rise
Monday, April 29, 2019 by Approximately 21 million children worldwide are not having measles vaccinations every year, substantially increasing their risk of raising the risk of the disease later in life.

Throat lozenges could be contributing to antimicrobial resistance
Wednesday, April 24, 2019 by Over the counter (OTC) throat lozenges could be contributing to antimicrobial resistance (AMR) according to research presented at this year's European Congress of Clinical Microbiology...

Half of patients have suboptimal response to statins
Saturday, April 20, 2019 by Over half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, according to research published in the journal Heart.

New laws in China to ensure steady drug supply
Thursday, April 18, 2019 by China’s National Health Commission (NHC) has stated that it will monitor the country’s drugs market more closely in order to ensure a sufficient supply of essential medicines.

Huge cost of opioid epidemic
Monday, April 15, 2019 by New research from Pennsylvania State University has reported that the opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue.

Underwater forests a treasure trove of new drugs
Wednesday, April 10, 2019 by In light of the increasing resistant microbes, researchers are taking their search for drug candidates offshore. A new study published in Frontiers in Microbiology reported that a...

Epilepsy Society calls for review of UK supply chain after increase in access issues
Wednesday, April 10, 2019 by The Epilepsy Society has recently spoken out about the “steep rise” in UK patients experiencing difficulty in accessing seizure medication.

Call for temporary medicines export ban in light of no-deal Brexit outcome
Tuesday, April 02, 2019 by The UK pharma industry has called for a temporary medicines export ban to prevent the NHS from being hit by national drugs shortage in the event of no-deal Brexit.

NHS England’s medicines chief calls for faster market access
Tuesday, April 02, 2019 by NHS England now plays a key gatekeeper role for the industry’s high cost specialised medicines, and has become increasingly commercially savvy over recent years, working alongside...

SHL makes debut at APLAR-ARA 2019
Friday, March 15, 2019 by SHL Group will make its first appearance at the 21st Asia Pacific League of Associations for Rheumatology Congress from 8-11 April in Brisbane, Australia. The congress will be held...

UCSF discover potential new treatment approach for type 1 diabetes
Tuesday, February 26, 2019 by Researchers at the University of California, San Francisco (UCSF) Diabetes Centre have uncovered evidence to suggest assumptions about the cause of type 1 diabetes are incorrect,...

Greater Manchester backs move to outcome-based payment
Monday, February 25, 2019 by The trend towards paying for medicines based on patient outcomes (OBP) are growing in both the US and Europe

Editor's Choice Archive


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.